标题
Prostate cancer: ESMO Consensus Conference Guidelines 2012
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 24, Issue 5, Pages 1141-1162
出版商
Oxford University Press (OUP)
发表日期
2013-01-10
DOI
10.1093/annonc/mds624
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
- (2013) Roger Chou et al. ANNALS OF INTERNAL MEDICINE
- The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial
- (2012) Maria Frånlund et al. BJU INTERNATIONAL
- ESUR prostate MR guidelines 2012
- (2012) Jelle O. Barentsz et al. EUROPEAN RADIOLOGY
- Three-Tesla Magnetic Resonance–Guided Prostate Biopsy in Men With Increased Prostate-Specific Antigen and Repeated, Negative, Random, Systematic, Transrectal Ultrasound Biopsies: Detection of Clinically Significant Prostate Cancers
- (2012) Caroline M.A. Hoeks et al. EUROPEAN UROLOGY
- Infectious Complications and Hospital Admissions After Prostate Biopsy in a European Randomized Trial
- (2012) Stacy Loeb et al. EUROPEAN UROLOGY
- Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer
- (2012) M. L. Huber et al. JNCI-Journal of the National Cancer Institute
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
- (2012) G. L. Andriole et al. JNCI-Journal of the National Cancer Institute
- The FinnProstate Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer
- (2012) Arto J. Salonen et al. JOURNAL OF UROLOGY
- Prostate-Cancer Mortality at 11 Years of Follow-up
- (2012) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
- (2012) Juanita M. Crook et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radical Prostatectomy versus Observation for Localized Prostate Cancer
- (2012) Timothy J. Wilt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fourteen years of evolution of ESMO Guidelines: from the minimum recommendations to the Consensus Conference-derived guidelines
- (2011) N. Pavlidis et al. ANNALS OF ONCOLOGY
- Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer
- (2011) Sameer A. Siddiqui et al. BJU INTERNATIONAL
- High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy
- (2011) Richard Savdie et al. BJU INTERNATIONAL
- Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response
- (2011) C. J. Ryan et al. CLINICAL CANCER RESEARCH
- High-Dose Salvage Intensity-Modulated Radiotherapy With or Without Androgen Deprivation After Radical Prostatectomy for Rising or Persisting Prostate-Specific Antigen: 5-Year Results
- (2011) Piet Ost et al. EUROPEAN UROLOGY
- Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely?
- (2011) Monique J. Roobol EUROPEAN UROLOGY
- Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate Cancer
- (2011) Alessandro Sciarra et al. EUROPEAN UROLOGY
- Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Multi-institutional Collaboration
- (2011) Daher C. Chade et al. EUROPEAN UROLOGY
- Prospective Evaluation of 11C-Choline Positron Emission Tomography/Computed Tomography and Diffusion-Weighted Magnetic Resonance Imaging for the Nodal Staging of Prostate Cancer with a High Risk of Lymph Node Metastases
- (2011) Tom Budiharto et al. EUROPEAN UROLOGY
- Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2–4 pN+ Prostate Cancer: Results of a Matched Analysis
- (2011) Alberto Briganti et al. EUROPEAN UROLOGY
- Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores
- (2011) Alberto Briganti et al. EUROPEAN UROLOGY
- Concurrent Androgen Deprivation Therapy During Salvage Prostate Radiotherapy Improves Treatment Outcomes in High-Risk Patients
- (2011) Daniel E. Soto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Population screening for prostate cancer: An overview of available studies and meta-analysis
- (2011) Nicolaas Lumen et al. INTERNATIONAL JOURNAL OF UROLOGY
- Androgen Deprivation Therapy and Cardiovascular Risk
- (2011) Sanoj Punnen et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular Toxicity of Androgen Deprivation Therapy: A New Door Opens
- (2011) Shabbir M.H. Alibhai JOURNAL OF CLINICAL ONCOLOGY
- Active Surveillance for Prostate Cancer: Progress and Promise
- (2011) Matthew R. Cooperberg et al. JOURNAL OF CLINICAL ONCOLOGY
- An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection
- (2011) Andrew J. Vickers et al. JNCI-Journal of the National Cancer Institute
- Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
- (2011) Padraig Warde et al. LANCET
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial
- (2011) Eva Johansson et al. LANCET ONCOLOGY
- Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial
- (2011) David Dearnaley et al. LANCET ONCOLOGY
- One Man at a Time — Resolving the PSA Controversy
- (2011) Mary F. McNaughton-Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
- (2011) Anna Bill-Axelson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Salvage radiotherapy after prostatectomy – What is the best time to treat?
- (2011) Alessandra Siegmann et al. RADIOTHERAPY AND ONCOLOGY
- Dose Escalation for Patients with Decreasing PSA during Radiotherapy for Elevated PSA after Radical Prostatectomy Improves Biochemical Progression-Free Survival
- (2011) Alessandra Siegmann et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group
- (2011) Donna P. Ankerst et al. WORLD JOURNAL OF UROLOGY
- Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group
- (2011) Monique J. Roobol et al. WORLD JOURNAL OF UROLOGY
- The Gleason Score of Tumor at the Margin in Radical Prostatectomy is Predictive of Biochemical Recurrence
- (2010) Dengfeng Cao et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) A. Horwich et al. ANNALS OF ONCOLOGY
- Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching
- (2010) Ahmed Magheli et al. BJU INTERNATIONAL
- Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study
- (2010) Jean-Christophe Eymard et al. BJU INTERNATIONAL
- The influence of family history on prostate cancer risk: implications for clinical management
- (2010) Stephan Madersbacher et al. BJU INTERNATIONAL
- Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years
- (2010) Peter Iversen et al. BJU INTERNATIONAL
- Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT
- (2010) Israel Deutsch et al. Brachytherapy
- Introducing the 2010 American Cancer Society Prostate Cancer Screening Guideline
- (2010) O. W. Brawley et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The interval from the last cycle of docetaxel-based chemotherapy to progression is associated with the efficacy of subsequent docetaxel in patients with prostate cancer
- (2010) Yohann Loriot et al. EUROPEAN JOURNAL OF CANCER
- Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies
- (2010) J.A. Lane et al. EUROPEAN JOURNAL OF CANCER
- Estimates of cancer incidence and mortality in Europe in 2008
- (2010) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Survival Benefit of Radical Prostatectomy in Lymph Node–Positive Patients with Prostate Cancer
- (2010) Jutta Engel et al. EUROPEAN UROLOGY
- Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting
- (2010) Louise Dickinson et al. EUROPEAN UROLOGY
- Dose Escalation and Quality of Life in Patients With Localized Prostate Cancer Treated With Radiotherapy: Long-Term Results of the Dutch Randomized Dose-Escalation Trial (CKTO 96-10 Trial)
- (2010) Abrahim Al-Mamgani et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity in Patients With Castration-Resistant Prostate Cancer Who Received Prior Ketoconazole Therapy
- (2010) Charles J. Ryan et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09
- (2010) Anthony L. Zietman et al. JOURNAL OF CLINICAL ONCOLOGY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
- (2010) Jonas Hugosson et al. LANCET ONCOLOGY
- External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
- (2010) Michel Bolla et al. LANCET ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation
- (2010) Martin Spahn et al. UROLOGIA INTERNATIONALIS
- Tumor Grade at Margins of Resection in Radical Prostatectomy Specimens Is an Independent Predictor of Prognosis
- (2010) Fadi Brimo et al. UROLOGY
- Prostate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time
- (2009) Michael K. Ng et al. BJU INTERNATIONAL
- Radiation dose escalation for localized prostate cancer
- (2009) William W. Wong et al. CANCER
- Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: A systematic review and meta-analysis of randomised trials
- (2009) M.D. Shelley et al. CANCER TREATMENT REVIEWS
- European Association of Urology Position Statement on Screening for Prostate Cancer
- (2009) Per-Anders Abrahamsson et al. EUROPEAN UROLOGY
- Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group
- (2009) Fernando E.C. Calais da Silva et al. EUROPEAN UROLOGY
- Long-Term Follow-up of Patients with Prostate Cancer and Nodal Metastases Treated by Pelvic Lymphadenectomy and Radical Prostatectomy: The Positive Impact of Adjuvant Radiotherapy
- (2009) Luigi F. Da Pozzo et al. EUROPEAN UROLOGY
- Prognostic Parameters, Complications, and Oncologic and Functional Outcome of Salvage Radical Prostatectomy for Locally Recurrent Prostate Cancer after 21st-Century Radiotherapy
- (2009) Axel Heidenreich et al. EUROPEAN UROLOGY
- Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
- (2009) Per-Anders Abrahamsson EUROPEAN UROLOGY
- A Risk-Based Strategy Improves Prostate-Specific Antigen–Driven Detection of Prostate Cancer
- (2009) Monique J. Roobol et al. EUROPEAN UROLOGY
- Efficacy of Salvage Radiotherapy Plus 2-Year Androgen Suppression for Postradical Prostatectomy Patients With PSA Relapse
- (2009) Richard Choo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials
- (2009) Gustavo Arruda Viani et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Need for High Radiation Dose (≥70 Gy) in Early Postoperative Irradiation After Radical Prostatectomy: A Single-Institution Analysis of 334 High-Risk, Node-Negative Patients
- (2009) Cesare Cozzarini et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Long-Term Toxicity Following 3D Conformal Radiation Therapy for Prostate Cancer From the RTOG 9406 Phase I/II Dose Escalation Study
- (2009) Jeff M. Michalski et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Salvage Radiotherapy for Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer: Dose–Response Analysis
- (2009) Johnny Ray Bernard et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy
- (2009) Jim C. Hu JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95
- (2009) Thomas Wiegel et al. JOURNAL OF CLINICAL ONCOLOGY
- 15-Year Followup of a Population Based Prostate Cancer Screening Study
- (2009) Anders Kjellman et al. JOURNAL OF UROLOGY
- Location, Extent and Number of Positive Surgical Margins Do Not Improve Accuracy of Predicting Prostate Cancer Recurrence After Radical Prostatectomy
- (2009) Andrew J. Stephenson et al. JOURNAL OF UROLOGY
- Prostate Specific Antigen Best Practice Statement: 2009 Update
- (2009) Kirsten L. Greene et al. JOURNAL OF UROLOGY
- Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
- (2009) Ian M. Thompson et al. JOURNAL OF UROLOGY
- Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
- (2009) David P Dearnaley et al. LANCET ONCOLOGY
- Prostate kallikrein markers in diagnosis, risk stratification and prognosis
- (2009) David Ulmert et al. Nature Reviews Urology
- Duration of Androgen Suppression in the Treatment of Prostate Cancer
- (2009) Michel Bolla et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa
- (2008) D. R. Berthold et al. ANNALS OF ONCOLOGY
- The postchemotherapy PSA surge syndrome
- (2008) R. Thuret et al. ANNALS OF ONCOLOGY
- The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
- (2008) Laurence Klotz et al. BJU INTERNATIONAL
- Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques
- (2008) Amy E. Krambeck et al. BJU INTERNATIONAL
- A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
- (2008) Andrew J Vickers et al. BMC Medicine
- The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis
- (2008) A.M. Hövels et al. CLINICAL RADIOLOGY
- Current decision-making in prostate cancer therapy
- (2008) Jared Cox et al. CURRENT OPINION IN UROLOGY
- The Role of the Digital Rectal Examination in Subsequent Screening Visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
- (2008) Claartje Gosselaar et al. EUROPEAN UROLOGY
- Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02
- (2008) Jason A. Efstathiou et al. EUROPEAN UROLOGY
- The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review
- (2008) Fritz Schröder et al. EUROPEAN UROLOGY
- Digital Rectal Examination and the Diagnosis of Prostate Cancer—a Study Based on 8 Years and Three Screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
- (2008) Claartje Gosselaar et al. EUROPEAN UROLOGY
- Early Versus Delayed Endocrine Treatment of T2-T3 pN1-3 M0 Prostate Cancer Without Local Treatment of the Primary Tumour: Final Results of European Organisation for the Research and Treatment of Cancer Protocol 30846 After 13 Years of Follow-up (A Randomised Controlled Trial)
- (2008) Fritz H. Schröder et al. EUROPEAN UROLOGY
- Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly
- (2008) Roderick C.N. van den Bergh et al. EUROPEAN UROLOGY
- Androgen Deprivation Therapy for the Treatment of Prostate Cancer: Consider Both Benefits and Risks
- (2008) Hendrik Isbarn et al. EUROPEAN UROLOGY
- Improved Outcomes With Higher Doses for Salvage Radiotherapy After Prostatectomy
- (2008) Christopher R. King et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiotherapy After Prostatectomy: Is the Evidence for Dose Escalation out There?
- (2008) Christopher R. King et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Long-Term Results of Conformal Radiotherapy for Prostate Cancer: Impact of Dose Escalation on Biochemical Tumor Control and Distant Metastases-Free Survival Outcomes
- (2008) Michael J. Zelefsky et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Achieving an Undetectable PSA After Radiotherapy for Biochemical Progression After Radical Prostatectomy Is an Independent Predictor of Biochemical Outcome—Results of a Retrospective Study
- (2008) Thomas Wiegel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy
- (2008) Bruce J. Trock JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study
- (2008) Dominik R. Berthold et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
- (2008) Gerhardt Attard et al. JOURNAL OF CLINICAL ONCOLOGY
- Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer
- (2008) Eric M. Horwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Complications of Pelvic Lymphadenectomy in 1,380 Patients Undergoing Radical Retropubic Prostatectomy Between 1993 and 2006
- (2008) Michael Musch et al. JOURNAL OF UROLOGY
- Timing of Androgen Deprivation Therapy and its Impact on Survival After Radical Prostatectomy: A Matched Cohort Study
- (2008) Sameer A. Siddiqui et al. JOURNAL OF UROLOGY
- Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
- (2008) Anders Widmark et al. LANCET
- A graphical device to represent the outcomes of a logistic regression analysis
- (2008) Ries Kranse et al. PROSTATE
- Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer
- (2007) Tomasz M. Beer et al. CANCER
- An Analysis of Radical Prostatectomy in Advanced Stage and High-Grade Prostate Cancer
- (2007) Hendrik Van Poppel et al. EUROPEAN UROLOGY
- Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891)
- (2007) Urs E. Studer et al. EUROPEAN UROLOGY
- Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer
- (2007) Deborah A. Kuban et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now